INS and type 1 diabetes mellitus: It has been shown that protein biomarkers are particularly useful in T1D; the appearance of islet autoantibodies marks the initiation of immune-mediated processes that can lead to beta cell destruction and T1D, and C-peptide can be measured to evaluate residual endogenous insulin production.